SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000264
Filing Date
2021-05-17
Accepted
2021-05-17 16:31:14
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-20210331.htm   iXBRL 10-Q 1008988
2 EX-31.1 clsd-20210331-ex31_1.htm EX-31.1 13954
3 EX-31.2 clsd-20210331-ex31_2.htm EX-31.2 13674
4 EX-32.1 clsd-20210331-ex32_1.htm EX-32.1 9564
5 GRAPHIC img139628049_0.jpg GRAPHIC 50833
  Complete submission text file 0000950170-21-000264.txt   4586360

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20210331_lab.xml EX-101.LAB 360791
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20210331.xsd EX-101.SCH 42836
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsd-20210331_def.xml EX-101.DEF 145360
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20210331_pre.xml EX-101.PRE 257466
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsd-20210331_cal.xml EX-101.CAL 33804
11 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20210331_htm.xml XML 651810
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 21931350
SIC: 2834 Pharmaceutical Preparations